Skip to main content
OpenTrials

Clinical trial condition

Noonan Syndrome

Explore clinical trials studying Noonan Syndrome. Study availability and eligibility vary by location and protocol.

37 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Noonan Syndrome trial results

Recruiting

Solid Tumors in RASopathies

NCT05761314

Conditions
Abnormalities, Multiple, Cardio-Facio-Cutaneous Syndrome, Cardiofaciocutaneous syndrome, +15 more
Locations
  • Department of Woman and Child Health and Public Health, Fondazione Policlinico A. Gemelli, IRCCS Roma, Italy
View Trial Details
Completed

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

NCT04045496

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Washington University School of Medicine Seattle, Washington, United States
View Trial Details
Completed

A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China

NCT04121286

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical Collage Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View Trial Details
Completed

A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors

NCT03518554

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +40 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions